Ticker: ACLX

09:26am, Monday, Dec 08, 2025

Arcellx Shares Jump After Strong Multiple Myeloma Therapy Results

Arcellx (NASDAQ:ACLX) stock jumps on promising Phase 2 data for anito-cel, showing high response rates and durable outcomes in difficult-to-treat multiple myeloma patients.